El interés en corto de Schmid Group da a los inversores una idea del grado en que los inversores apuestan por la caída de las acciones de Schmid Group. Los datos de interés en corto se actualizan cada dos semanas.

Schmid Group (NASDAQ:SHMD) Bolsa, Informe de interés en corto

Schmid Group NV is a global supplier of equipment, software and services for various industries such as printed circuit board (PCB), substrate manufacturing, photovoltaics, and glass and energy storage with a focus on the highest end of this market in terms of technology and performance. It focuses on a modular product portfolio of machinery to use in the manufacturing of high-end PCB equipment and semiconductor packaging devices which includes common flexible circuit fabrication techniques such as subtractive, semi-additive processes (SAP) and modified semi-additive processes (mSAP).

SCHMID Group N.V. - Class A Ordinary Shares

Schmid Group NV

Shimano Inc

Coherent (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/COHR#NYSE">COHR</a>) is looking for Q4 Adj EPS of $0.81-$1.01 vs $0.91 analyst estimate. sees sales of $1.425 billion-$1.575 billion vs $1.47 billion analyst estimate.

News

Guidance

COHR

Coherent Sees Q4 Adj EPS $0.81-$1.01 vs $0.91 Est; Sees Sales $1.425B-$1.575B vs $1.47B Est

Catalyst Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CPRX#NASDAQ">CPRX</a>) affirms FY2025 sales outlook from $545.00 million-$565.00 million to $545.00 million-$565.00 million vs $557.24 million estimate.

CPRX

Catalyst Pharmaceuticals Affirms FY2025 Sales Guidance of $545.00M-$565.00M vs $557.24M Est

Envela (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/ELA#AMEX">ELA</a>) reported quarterly earnings of $0.10 per share which beat the analyst consensus estimate of $0.07 by 42.86 percent. This is a 42.86 percent increase over earnings of $0.07 per share from the same period last year. The company reported quarterly sales of $48.26 million which beat the analyst consensus estimate of $43.83 million by 10.10 percent. This is a 21.07 percent increase over sales of $39.86 million the same period last year.

Earnings

Earnings Beats

Envela Q1 EPS $0.10 Beats $0.07 Estimate, Sales $48.26M Beat $43.83M Estimate

Second Quarter 2025 Guidance
<ul>
<li>Revenue of $925 million, plus or minus $40 million</li>
<li>Gross margin of 46.5%, plus or minus 1.0%</li>
<li>GAAP operating expenses of $316 million, plus or minus $5 million and Non-GAAP operating expenses of $252 million, plus or minus $5 million</li>
<li>GAAP net income of $55 million, plus or minus $21 million and Non-GAAP net earnings of $106 million, plus or minus $19 million</li>
<li>GAAP net income per diluted share of $0.81, plus or minus $0.32 and Non-GAAP net earnings per diluted share of $1.56, plus or minus $0.28</li>
<li>Adjusted EBITDA of $216 million, plus or minus $23 million</li>
</ul>

MKSI

MKS Instruments Sees Q2 GAAP EPS $0.49-$1.13 vs $1.12 Est

Catalyst Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CPRX#NASDAQ">CPRX</a>) reported quarterly earnings of $0.68 per share which beat the analyst consensus estimate of $0.53 by 28.3 percent. This is a 78.95 percent increase over earnings of $0.38 per share from the same period last year. The company reported quarterly sales of $141.42 million which beat the analyst consensus estimate of $130.86 million by 8.07 percent. This is a 43.56 percent increase over sales of $98.51 million the same period last year.

Catalyst Pharmaceuticals Q1 Adj. EPS $0.68 Beats $0.53 Estimate, Sales $141.42M Beat $130.86M Estimate

Xencor (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XNCR#NASDAQ">XNCR</a>) reported quarterly losses of $(0.66) per share which missed the analyst consensus estimate of $(0.60) by 10 percent. This is a 40.54 percent increase over losses of $(1.11) per share from the same period last year. The company reported quarterly sales of $32.73 million which beat the analyst consensus estimate of $22.41 million by 46.03 percent. This is a 155.62 percent increase over sales of $12.80 million the same period last year.

Earnings Misses

XNCR

Xencor Q1 EPS $(0.66) Misses $(0.60) Estimate, Sales $32.73M Beat $22.41M Estimate

Sunrun Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RUN#NASDAQ">RUN</a>) released its first-quarter results after Wednesday's closing bell. Here's a look at the key figures<a href="https://www.benzinga.com/pressreleases/25/05/g45265483/sunrun-reports-first-quarter-2025-financial-results"> from the report. </a>
The Details: Sunrun reported quarterly earnings of 20 cents per share, which beat the analyst consensus estimate of losses of 25 cents. Quarterly revenue came in at $504.27 million, which beat the consensus estimate of $484.06 million, and represented a 10% increase over revenue of $458.19 million from the same period last year.
Read Next: <a href="https://www.benzinga.com/general/travel/25/05/45260938/disneys-new-abu-dhabi-theme-park-will-be-authentically-disney-and-distinctly-emirati-ceo-bob-iger-says?utm_source=articleShare">Disney&#8217;s New Abu Dhabi Theme Park Will Be &#8216;Authentically Disney And Distinctly Emirati,&#8217; CEO Bob Iger Says&nbsp;</a>
For the first quarter, Sunrun reported: 
<ul>
<li>Aggregate Subscriber Value of $1.2 billion, 23% growth year-over-year. </li>
<li>Contracted Net Value Creation of $164 million, 104% growth year-over-year. </li>
<li>Cash Generation of $56 million, the fourth consecutive quarter of positive cash generation. </li>
</ul>
&#8220;The first quarter was another strong quarter for Sunrun as we exceeded our volume and Cash Generation targets by significant margins in what is seasonally the slowest quarter of the year,&#8221;  said Mary Powell, Sunrun&#8217;s CEO. &#8220;We are focused on delivering the best product for customers, underwriting volumes with strong unit margins, optimizing our routes to market, and driving cost discipline, including leveraging AI for innovation, creating significant operating efficiencies and quality enhancement. This has allowed us to gain market share in recent periods and produce strong operating and financial results.&#8221;
RUN Price Action: According to data from <a href="https://pro.benzinga.com/?gspk=YWRhbWVja2VydDUzMzY&amp;gsxid=zBMR4PKmcgBw">Benzinga Pro</a>, Sunrun stock was up 8.25% at $8.00 after hours Wednesday.&nbsp;&nbsp;
Read Next:&nbsp;
<ul>
<li><a href="https://www.benzinga.com/general/biotech/25/05/45239803/sarepta-therapeutics-stock-plummets-after-q1-results-heres-why?utm_source=articleShare">Sarepta Therapeutics Stock Plummets After Q1 Results: Here&#8217;s Why&nbsp;</a></li>
</ul>
Photo: Shutterstock

Movers

Tech

Sunrun Stock Rallies After Strong Q1 Report: Details

WIIM

Tutor Perini shares are trading higher after the company reported better-than-expected Q1 financial results and raised its FY25 EPS guidance with its midpoint above estimates.

QVCGB

QVC Group shares are trading lower after the company reported a year-over-year decrease in Q1 EPS and revenue results.

Encore Capital Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ECPG#NASDAQ">ECPG</a>) reported quarterly earnings of $1.93 per share which beat the analyst consensus estimate of $1.21 by 59.5 percent. This is a 103.16 percent increase over earnings of $0.95 per share from the same period last year. The company reported quarterly sales of $392.77 million which beat the analyst consensus estimate of $374.49 million by 4.88 percent. This is a 19.61 percent increase over sales of $328.39 million the same period last year.

ECPG

Encore Capital Gr Q1 EPS $1.93 Beats $1.21 Estimate, Sales $392.77M Beat $374.49M Estimate

Beyond Meat (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BYND#NASDAQ">BYND</a>) sees Q2 sales of $80.000 million-$85.000 million vs $93.47 million analyst estimate.

BYND

Beyond Meat Sees Q2 Sales $80.000M-$85.000M vs $93.47M Est

MKS Instruments Sees Q2 Adj EPS $1.28-$1.84 vs $1.66 Est; Sees Sales $885.000M-$965.000M vs $937.59M Est

Carvana Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CVNA#NYSE">CVNA</a>) reported first-quarter financial results Wednesday after the bell. Here&#8217;s a rundown of the <a href="https://www.benzinga.com/pressreleases/25/05/b45265795/carvana-announces-record-first-quarter-2025-results">used car retailer&#8217;s report</a>.
Q1 Earnings: Carvana reported first-quarter revenue of $4.23 billion, beating the&nbsp;<a href="http://benzinga.com/quote/CVNA/earnings" target="_blank" rel="noreferrer noopener">consensus estimate</a>&nbsp;of $3.98 billion. The company reported first-quarter earnings of $1.51 per share, smashing analyst estimates of 60 cents per share.
Carvana has now exceeded analyst estimates on the top and bottom lines in five consecutive quarters, according to <a href="http://pro.benzinga.com">Benzinga Pro</a>.
Total revenue increased 38% year-over-year after Carvana sold 133,898 vehicles in the first quarter. Vehicle sales were up 46% on a year-over-year basis.
&#8220;In&nbsp;Q1, Carvana set a new record for retail units while also driving record profitability and hitting our highest customer net promoter score in nearly three years,&#8221; said&nbsp;Ernie Garcia, co-founder and CEO of Carvana.
&#8220;We are incredibly well-positioned for the path ahead and have very clear visibility to even stronger financial performance, much larger scales, and even better customer experiences.&#8221;
Guidance:&nbsp;Carvana expects a sequential increase in retail units sold and adjusted EBITDA in the second quarter. The company said it remains on track to deliver &#8220;significant growth&#8221; in both retail units sold and adjusted EBITDA in full-year 2025.
&#8220;After four consecutive quarters of over 30% retail unit growth paired with Adjusted EBITDA margins consistently within its long-term financial model range, the company announced its next management objective: to sell 3 million retail units per year at an Adjusted EBITDA margin of 13.5% within five to 10 years,&#8221; the company said in the earnings release.
Carvana&#8217;s management team will further discuss the quarter on a call with investors and analysts at 5:30 p.m. ET.
CVNA Price Action: <a href="https://www.benzinga.com/quote/CVNA" target="_blank" rel="noreferrer noopener">Carvana shares</a> were down 5.43% after-hours, trading at $246 at the time of publication Wednesday, according to <a href="http://pro.benzinga.com/" target="_blank" rel="noreferrer noopener">Benzinga Pro</a>.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/economics/macro-economic-events/25/05/45263291/fed-keeps-rates-steady-warns-of-rising-uncertainty-about-the-economic-outlook">Fed Keeps Rates Steady, Warns Of Rising &#8216;Uncertainty About The Economic Outlook&#8217;</a></li>
</ul>
<ul>
<li><a href="https://www.benzinga.com/markets/25/04/44778739/elon-musks-political-fallout-fuels-record-dump-of-used-tesla-cars-now-selling-for-thousands-below-market-value">Elon Musk&#8217;s Political Fallout Fuels Record Dump of Used Tesla Cars — Now Selling For Thousands Below Market Value</a></li>
</ul>
Photo: Shutterstock.

After-Hours Center

CVNA

Carvana Q1 Earnings: Revenue, EPS Beat Estimates As Vehicles Sales Jump 46%, Company Remains On Track For 'Significant Growth' In FY25

Hudson Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HDSN#NASDAQ">HDSN</a>) reported quarterly earnings of $0.06 per share which beat the analyst consensus estimate of $0.05 by 20 percent. This is a 70 percent decrease over earnings of $0.20 per share from the same period last year. The company reported quarterly sales of $55.34 million which beat the analyst consensus estimate of $52.23 million by 5.95 percent. This is a 15.18 percent decrease over sales of $65.25 million the same period last year.

HDSN

Hudson Technologies Q1 EPS $0.06 Beats $0.05 Estimate, Sales $55.34M Beat $52.23M Estimate

Flutter Entertainment (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FLUT#NYSE">FLUT</a>) raises FY2025 sales outlook from $15.48 billion-$16.38 billion to $16.63 billion-$17.53 billion vs $16.59 billion estimate.

FLUT

Flutter Entertainment Raises FY2025 Sales Guidance from $15.48B-$16.38B to $16.63B-$17.53B vs $16.59B Est

Nine Energy Service (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NINE#NYSE">NINE</a>) reported quarterly losses of $(0.18) per share which missed the analyst consensus estimate of $(0.15) by 20 percent. This is a 25 percent increase over losses of $(0.24) per share from the same period last year. The company reported quarterly sales of $150.47 million which beat the analyst consensus estimate of $149.20 million by 0.85 percent. This is a 5.87 percent increase over sales of $142.12 million the same period last year.

NINE

Nine Energy Service Q1 EPS $(0.18) Misses $(0.15) Estimate, Sales $150.47M Beat $149.20M Estimate

StoneX Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SNEX#NASDAQ">SNEX</a>) reported quarterly earnings of $1.41 per share which beat the analyst consensus estimate of $1.32 by 6.82 percent. This is a 23.68 percent increase over earnings of $1.14 per share from the same period last year. The company reported quarterly sales of $956.00 million which beat the analyst consensus estimate of $475.49 million by 101.06 percent. This is a 16.84 percent increase over sales of $818.20 million the same period last year.

SNEX

StoneX Group Q2 EPS $1.41 Beats $1.32 Estimate, Sales $956.00M Beat $475.49M Estimate

Vaxcyte (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PCVX#NASDAQ">PCVX</a>) reported quarterly losses of $(1.04) per share which beat the analyst consensus estimate of $(1.11) by 6.31 percent. This is a 22.35 percent decrease over losses of $(0.85) per share from the same period last year.

PCVX

Vaxcyte Q1 EPS $(1.04) Beats $(1.11) Estimate

Q2 Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/QTWO#NYSE">QTWO</a>) raises FY2025 sales outlook from $772.00 million-$779.00 million to $776.00 million-$783.00 million vs $775.79 million estimate.

QTWO

Q2 Holdings Raises FY2025 Sales Guidance from $772.00M-$779.00M to $776.00M-$783.00M vs $775.79M Est

Q2 Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/QTWO#NYSE">QTWO</a>) sees Q2 sales of $191.000 million-$195.000 million vs $191.72 million analyst estimate.

Comments

Schmid Group

Interés en corto

Schmid Group (NASDAQ:SHMD) Bolsa, Informe de interés en corto

La gente también mira

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL